Darzalex (daratumumab) - J&J
Rituxan (rituximab) - Roche
Nulojix (belatacept) - BMS
Recurrent FSGS Due to Anti-Nephrin Antibodies After Kidney Transplantation: A Case Report (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0784; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "We report recurrent anti-nephrin–associated FSGS post-kidney transplantation, treated with plasmapheresis, rituximab, and daratumumab...CNI was stopped due to intolerance, and was transitioned to monthly belatacept, MMF, and low-dose prednisone...Anti-CD38 therapy may be considered in refractory cases after expert consultation. Trend of Urine ACR After Kidney Tx" 
Case report • Clinical • Focal Segmental Glomerulosclerosis • Glomerulonephritis • Nephrology • Transplantation
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559280
 
Sandip Ghimire; Pooja Sanghi
 
Oct 2, 2026
 
Prev Next